Back to search

Article

Sentinel surveillance of the WHO-validated Pfkelch13 C580Y artemisinin resistance marker in Plasmodium falciparum isolates from Bangui, Central African Republic

2026-05-04

Abstract excerpt

<title>Abstract</title> <p>Background Artemisinin-based combination therapies (ACTs) are the cornerstone of malaria treatment. However, partial artemisinin resistance associated with mutations in the Plasmodium falciparum kelch13 (pfk13) propeller domain threatens malaria control efforts. The C580Y substitution is the principal World Health Organization (WHO) validated molecular marker for resistance surveillanc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bfad8cf3-f5a0-5d65-88db-c7a6c766084c
DOI
10.21203/rs.3.rs-9399260/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Sentinel surveillance of the WHO-validated Pfkelch13 C580Y artemisinin resistance marker in Plasmodium falciparum isolates from Bangui, Central African RepublicDOI 10.21203/rs.3.rs-9399260/v1
Select a neighboring publication to make it the new centre.